Prostaglandin compositions and method of treatment for male erectile dysfunction
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- NEXMED HLDG INC
- Publication Date
- 2003-01-29
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
field of invention
[0001] The present invention relates to compositions and methods suitable for treating erectile dysfunction, and more particularly to methods and pharmaceutical compositions suitable for intrascaphoid administration to the scaphoid fossa of a patient. Background of the invention
[0002] The term "impotence" is used to describe a male's inability to achieve and maintain an erection of the penis sufficient for satisfactory sexual intercourse. The term "erectile dysfunction" has been suggested as a more accurate term "denoting a male's inability to achieve penile erection as part of a multifaceted approach to overall male sexual function." Droller, M.J. et al. Impotence. Consensus Development Conference Statement, National Institutes of Health (1993).
[0003] The cause of erectile dysfunction may be psychological (psychogenic erectile dysfunction) or organic or both. Organ causes include physiological, neurological, vascular and hormonal pathologies or co...